Last update 01 Nov 2024

Carglumic acid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(2S)-2-(carbamoylamino)pentanedioic acid, (S)-2-ureidopentanedioic acid, Carbamino-L-glutamic acid
+ [15]
Target
Mechanism
CPS1 activators(Carbamoyl phosphate synthetase 1 activators)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
EU (24 Jan 2003),
RegulationOrphan Drug (JP), Priority Review (CN)
Login to view timeline

Structure

Molecular FormulaC6H10N2O5
InChIKeyLCQLHJZYVOQKHU-VKHMYHEASA-N
CAS Registry1188-38-1

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Acidemia, Isovaleric
IS
23 Jun 2017
Acidemia, Isovaleric
NO
23 Jun 2017
Acidemia, Isovaleric
LI
23 Jun 2017
Acidemia, Isovaleric
EU
23 Jun 2017
Methylmalonic Acidemia
IS
23 Jun 2017
Methylmalonic Acidemia
NO
23 Jun 2017
Methylmalonic Acidemia
EU
23 Jun 2017
Methylmalonic Acidemia
LI
23 Jun 2017
N-Acetyl Glutamate Synthetase Deficiency
LI
23 Jun 2017
N-Acetyl Glutamate Synthetase Deficiency
EU
23 Jun 2017
N-Acetyl Glutamate Synthetase Deficiency
NO
23 Jun 2017
N-Acetyl Glutamate Synthetase Deficiency
IS
23 Jun 2017
Propionic Acidemia
EU
23 Jun 2017
Propionic Acidemia
LI
23 Jun 2017
Propionic Acidemia
IS
23 Jun 2017
Propionic Acidemia
NO
23 Jun 2017
Hyperammonemia
IS
24 Jan 2003
Hyperammonemia
EU
24 Jan 2003
Hyperammonemia
NO
24 Jan 2003
Hyperammonemia
LI
24 Jan 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
10
ivqwgcxpmy(pwmlvjmtsv) = hmnrcgzkux jstltgqfvy (vsfwwsnfxa )
-
10 Jan 2024
Phase 3
38
avthnlotaq(ropjbblxen) = kvpesarvyk nsolorzzlv (swivgktoxm )
Superior
11 Oct 2021
Standard treatment
avthnlotaq(ropjbblxen) = hyeundccsf nsolorzzlv (swivgktoxm )
Not Applicable
-
dqhymhbpvf(ltyleobghk) = ezsvodtkfb ndqgzuolyn (cparhwtcgs )
-
25 Aug 2019
Phase 2
1
Standard of Care
gosimkcasv(vkufjfxjnt) = yjinjdmqyf xsxdqfgqwd (logjjrswvz, ugzctzdpqf - ukvghsghwf)
-
26 Apr 2017
Phase 2
7
agrrnnwzzi(aeitftxhjf) = oifupjuimj hkdrrpnxxd (qxsxlscqpf )
-
01 Jul 2010
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free